+ Watch NVO
on My Watchlist
Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.
Zacks Rank 1-StrongBuy, Recommend OutPerform, Industry Rank 29 / 265, Target 173.80, Avg target of 5 analyst 182.60- Short Interest Ratio: 4.03 - Est Revision Ratio: Up 12 vs 0 Down
keep position open as long as stock trades between 152 -> 169
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions